Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy.
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy. Leuk Lymphoma. 2015; 56(11):3096-102.
View in:
PubMed
subject areas
Adolescent
Adolescent
Adult
Adult
Aged
Aged
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Biomarkers
Biomarkers
Bleomycin
Bleomycin
Combined Modality Therapy
Combined Modality Therapy
Dacarbazine
Dacarbazine
Doxorubicin
Doxorubicin
Female
Female
Ferritins
Ferritins
Hodgkin Disease
Hodgkin Disease
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Prognosis
Prognosis
Radiotherapy
Radiotherapy
Retrospective Studies
Retrospective Studies
ROC Curve
ROC Curve
Survival Analysis
Survival Analysis
Treatment Outcome
Treatment Outcome
Vinblastine
Vinblastine
Young Adult
Young Adult
authors with profiles
Jesus E Medina